nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—ALB—Estropipate—osteoporosis	0.115	0.169	CbGbCtD
Sulfamethoxazole—CYP2C9—Estropipate—osteoporosis	0.0618	0.0911	CbGbCtD
Sulfamethoxazole—CYP2C8—Raloxifene—osteoporosis	0.0591	0.0872	CbGbCtD
Sulfamethoxazole—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0571	0.0842	CbGbCtD
Sulfamethoxazole—ALB—Estradiol—osteoporosis	0.0476	0.0702	CbGbCtD
Sulfamethoxazole—CYP2C8—Cholecalciferol—osteoporosis	0.0457	0.0673	CbGbCtD
Sulfamethoxazole—CYP2C8—Estradiol—osteoporosis	0.0368	0.0542	CbGbCtD
Sulfamethoxazole—CYP3A4—Estropipate—osteoporosis	0.0359	0.053	CbGbCtD
Sulfamethoxazole—CYP3A4—Calcitriol—osteoporosis	0.0359	0.053	CbGbCtD
Sulfamethoxazole—CYP2C9—Cholecalciferol—osteoporosis	0.0318	0.0469	CbGbCtD
Sulfamethoxazole—CYP3A4—Ergocalciferol—osteoporosis	0.0287	0.0423	CbGbCtD
Sulfamethoxazole—CYP2C9—Estradiol—osteoporosis	0.0257	0.0378	CbGbCtD
Sulfamethoxazole—CYP3A4—Raloxifene—osteoporosis	0.024	0.0353	CbGbCtD
Sulfamethoxazole—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0232	0.0341	CbGbCtD
Sulfamethoxazole—CYP3A4—Cholecalciferol—osteoporosis	0.0185	0.0273	CbGbCtD
Sulfamethoxazole—CYP3A4—Conjugated Estrogens—osteoporosis	0.017	0.0251	CbGbCtD
Sulfamethoxazole—CYP3A4—Estradiol—osteoporosis	0.0149	0.022	CbGbCtD
Sulfamethoxazole—Sulfathiazole—CYP19A1—osteoporosis	0.00179	0.646	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CA2—osteoporosis	0.000977	0.353	CrCbGaD
Sulfamethoxazole—Cough—Pamidronate—osteoporosis	0.000398	0.00154	CcSEcCtD
Sulfamethoxazole—Convulsion—Pamidronate—osteoporosis	0.000395	0.00153	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000394	0.00152	CcSEcCtD
Sulfamethoxazole—Tension—Conjugated Estrogens—osteoporosis	0.000393	0.00152	CcSEcCtD
Sulfamethoxazole—Urticaria—Estropipate—osteoporosis	0.000393	0.00152	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Raloxifene—osteoporosis	0.000392	0.00151	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Etidronic acid—osteoporosis	0.000392	0.00151	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Estropipate—osteoporosis	0.000391	0.00151	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Estropipate—osteoporosis	0.000391	0.00151	CcSEcCtD
Sulfamethoxazole—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00039	0.00151	CcSEcCtD
Sulfamethoxazole—Nervousness—Conjugated Estrogens—osteoporosis	0.000389	0.0015	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Estradiol—osteoporosis	0.000388	0.0015	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Ibandronate—osteoporosis	0.000388	0.0015	CcSEcCtD
Sulfamethoxazole—Myalgia—Pamidronate—osteoporosis	0.000388	0.0015	CcSEcCtD
Sulfamethoxazole—Arthralgia—Pamidronate—osteoporosis	0.000388	0.0015	CcSEcCtD
Sulfamethoxazole—Urticaria—Alendronate—osteoporosis	0.000387	0.0015	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Alendronate—osteoporosis	0.000385	0.00149	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Alendronate—osteoporosis	0.000385	0.00149	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Risedronate—osteoporosis	0.000384	0.00148	CcSEcCtD
Sulfamethoxazole—Angioedema—Zoledronate—osteoporosis	0.00038	0.00147	CcSEcCtD
Sulfamethoxazole—Skin disorder—Risedronate—osteoporosis	0.00038	0.00147	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Calcitriol—osteoporosis	0.00038	0.00147	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Raloxifene—osteoporosis	0.000379	0.00146	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Raloxifene—osteoporosis	0.000379	0.00146	CcSEcCtD
Sulfamethoxazole—Urticaria—Ibandronate—osteoporosis	0.000377	0.00146	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Ibandronate—osteoporosis	0.000375	0.00145	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Ibandronate—osteoporosis	0.000375	0.00145	CcSEcCtD
Sulfamethoxazole—Vertigo—Zoledronate—osteoporosis	0.000374	0.00144	CcSEcCtD
Sulfamethoxazole—Leukopenia—Zoledronate—osteoporosis	0.000373	0.00144	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Pamidronate—osteoporosis	0.000372	0.00144	CcSEcCtD
Sulfamethoxazole—Urticaria—Calcitriol—osteoporosis	0.000369	0.00143	CcSEcCtD
Sulfamethoxazole—Hepatitis—Estradiol—osteoporosis	0.000368	0.00142	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Calcitriol—osteoporosis	0.000367	0.00142	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Calcitriol—osteoporosis	0.000367	0.00142	CcSEcCtD
Sulfamethoxazole—Angioedema—Conjugated Estrogens—osteoporosis	0.000366	0.00141	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Estropipate—osteoporosis	0.000365	0.00141	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Pamidronate—osteoporosis	0.000365	0.00141	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Pamidronate—osteoporosis	0.000364	0.00141	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Estradiol—osteoporosis	0.000364	0.00141	CcSEcCtD
Sulfamethoxazole—Vomiting—Etidronic acid—osteoporosis	0.000364	0.00141	CcSEcCtD
Sulfamethoxazole—Cough—Zoledronate—osteoporosis	0.000363	0.0014	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Estradiol—osteoporosis	0.000362	0.0014	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Estradiol—osteoporosis	0.000361	0.0014	CcSEcCtD
Sulfamethoxazole—Rash—Etidronic acid—osteoporosis	0.000361	0.00139	CcSEcCtD
Sulfamethoxazole—Convulsion—Zoledronate—osteoporosis	0.000361	0.00139	CcSEcCtD
Sulfamethoxazole—Dermatitis—Etidronic acid—osteoporosis	0.00036	0.00139	CcSEcCtD
Sulfamethoxazole—Vertigo—Conjugated Estrogens—osteoporosis	0.00036	0.00139	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Alendronate—osteoporosis	0.000359	0.00139	CcSEcCtD
Sulfamethoxazole—Headache—Etidronic acid—osteoporosis	0.000358	0.00138	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000356	0.00138	CcSEcCtD
Sulfamethoxazole—Asthenia—Estropipate—osteoporosis	0.000355	0.00137	CcSEcCtD
Sulfamethoxazole—Anorexia—Pamidronate—osteoporosis	0.000355	0.00137	CcSEcCtD
Sulfamethoxazole—Myalgia—Zoledronate—osteoporosis	0.000354	0.00137	CcSEcCtD
Sulfamethoxazole—Arthralgia—Zoledronate—osteoporosis	0.000354	0.00137	CcSEcCtD
Sulfamethoxazole—Insomnia—Risedronate—osteoporosis	0.000354	0.00137	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000352	0.00136	CcSEcCtD
Sulfamethoxazole—Pruritus—Estropipate—osteoporosis	0.00035	0.00135	CcSEcCtD
Sulfamethoxazole—Asthenia—Alendronate—osteoporosis	0.00035	0.00135	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Ibandronate—osteoporosis	0.00035	0.00135	CcSEcCtD
Sulfamethoxazole—Cough—Conjugated Estrogens—osteoporosis	0.00035	0.00135	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Risedronate—osteoporosis	0.000349	0.00135	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Estradiol—osteoporosis	0.000348	0.00135	CcSEcCtD
Sulfamethoxazole—Convulsion—Conjugated Estrogens—osteoporosis	0.000347	0.00134	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000346	0.00134	CcSEcCtD
Sulfamethoxazole—Fatigue—Ethinyl Estradiol—osteoporosis	0.000346	0.00134	CcSEcCtD
Sulfamethoxazole—Pruritus—Alendronate—osteoporosis	0.000345	0.00133	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Risedronate—osteoporosis	0.000344	0.00133	CcSEcCtD
Sulfamethoxazole—Eye disorder—Estradiol—osteoporosis	0.000344	0.00133	CcSEcCtD
Sulfamethoxazole—Tinnitus—Estradiol—osteoporosis	0.000344	0.00133	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Calcitriol—osteoporosis	0.000342	0.00132	CcSEcCtD
Sulfamethoxazole—Arthralgia—Conjugated Estrogens—osteoporosis	0.000341	0.00132	CcSEcCtD
Sulfamethoxazole—Myalgia—Conjugated Estrogens—osteoporosis	0.000341	0.00132	CcSEcCtD
Sulfamethoxazole—Asthenia—Ibandronate—osteoporosis	0.000341	0.00132	CcSEcCtD
Sulfamethoxazole—Nausea—Etidronic acid—osteoporosis	0.00034	0.00131	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Zoledronate—osteoporosis	0.00034	0.00131	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000339	0.00131	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000339	0.00131	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Estropipate—osteoporosis	0.000339	0.00131	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Risedronate—osteoporosis	0.000338	0.0013	CcSEcCtD
Sulfamethoxazole—Fatigue—Risedronate—osteoporosis	0.000337	0.0013	CcSEcCtD
Sulfamethoxazole—Insomnia—Pamidronate—osteoporosis	0.000336	0.0013	CcSEcCtD
Sulfamethoxazole—Pruritus—Ibandronate—osteoporosis	0.000336	0.0013	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Alendronate—osteoporosis	0.000334	0.00129	CcSEcCtD
Sulfamethoxazole—Asthenia—Calcitriol—osteoporosis	0.000333	0.00129	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Zoledronate—osteoporosis	0.000333	0.00129	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Estradiol—osteoporosis	0.000333	0.00129	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Zoledronate—osteoporosis	0.000333	0.00128	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Estradiol—osteoporosis	0.000332	0.00128	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Pamidronate—osteoporosis	0.000332	0.00128	CcSEcCtD
Sulfamethoxazole—Chills—Estradiol—osteoporosis	0.000331	0.00128	CcSEcCtD
Sulfamethoxazole—Skin disorder—Zoledronate—osteoporosis	0.00033	0.00127	CcSEcCtD
Sulfamethoxazole—Pruritus—Calcitriol—osteoporosis	0.000329	0.00127	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000328	0.00127	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Raloxifene—osteoporosis	0.000328	0.00127	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Pamidronate—osteoporosis	0.000327	0.00126	CcSEcCtD
Sulfamethoxazole—Dizziness—Estropipate—osteoporosis	0.000327	0.00126	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000327	0.00126	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Ibandronate—osteoporosis	0.000325	0.00125	CcSEcCtD
Sulfamethoxazole—Anorexia—Zoledronate—osteoporosis	0.000324	0.00125	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Pamidronate—osteoporosis	0.000323	0.00125	CcSEcCtD
Sulfamethoxazole—Mental disorder—Estradiol—osteoporosis	0.000323	0.00125	CcSEcCtD
Sulfamethoxazole—Dizziness—Alendronate—osteoporosis	0.000322	0.00125	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000321	0.00124	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000321	0.00124	CcSEcCtD
Sulfamethoxazole—Malnutrition—Estradiol—osteoporosis	0.000321	0.00124	CcSEcCtD
Sulfamethoxazole—Fatigue—Pamidronate—osteoporosis	0.000321	0.00124	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Risedronate—osteoporosis	0.00032	0.00124	CcSEcCtD
Sulfamethoxazole—Urticaria—Ethinyl Estradiol—osteoporosis	0.000319	0.00123	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Calcitriol—osteoporosis	0.000318	0.00123	CcSEcCtD
Sulfamethoxazole—Skin disorder—Conjugated Estrogens—osteoporosis	0.000318	0.00123	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000317	0.00123	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000317	0.00123	CcSEcCtD
Sulfamethoxazole—Dizziness—Raloxifene—osteoporosis	0.000317	0.00122	CcSEcCtD
Sulfamethoxazole—Tension—Estradiol—osteoporosis	0.000315	0.00122	CcSEcCtD
Sulfamethoxazole—Vomiting—Estropipate—osteoporosis	0.000315	0.00122	CcSEcCtD
Sulfamethoxazole—Dizziness—Ibandronate—osteoporosis	0.000314	0.00121	CcSEcCtD
Sulfamethoxazole—Rash—Estropipate—osteoporosis	0.000312	0.00121	CcSEcCtD
Sulfamethoxazole—Dermatitis—Estropipate—osteoporosis	0.000312	0.0012	CcSEcCtD
Sulfamethoxazole—Anorexia—Conjugated Estrogens—osteoporosis	0.000312	0.0012	CcSEcCtD
Sulfamethoxazole—Nervousness—Estradiol—osteoporosis	0.000312	0.0012	CcSEcCtD
Sulfamethoxazole—Urticaria—Risedronate—osteoporosis	0.000311	0.0012	CcSEcCtD
Sulfamethoxazole—Headache—Estropipate—osteoporosis	0.00031	0.0012	CcSEcCtD
Sulfamethoxazole—Vomiting—Alendronate—osteoporosis	0.00031	0.0012	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00031	0.0012	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Risedronate—osteoporosis	0.000309	0.00119	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Risedronate—osteoporosis	0.000309	0.00119	CcSEcCtD
Sulfamethoxazole—Rash—Alendronate—osteoporosis	0.000307	0.00119	CcSEcCtD
Sulfamethoxazole—Insomnia—Zoledronate—osteoporosis	0.000307	0.00119	CcSEcCtD
Sulfamethoxazole—Dermatitis—Alendronate—osteoporosis	0.000307	0.00119	CcSEcCtD
Sulfamethoxazole—Headache—Alendronate—osteoporosis	0.000305	0.00118	CcSEcCtD
Sulfamethoxazole—Vomiting—Raloxifene—osteoporosis	0.000305	0.00118	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Pamidronate—osteoporosis	0.000304	0.00117	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Zoledronate—osteoporosis	0.000303	0.00117	CcSEcCtD
Sulfamethoxazole—Rash—Raloxifene—osteoporosis	0.000302	0.00117	CcSEcCtD
Sulfamethoxazole—Dermatitis—Raloxifene—osteoporosis	0.000302	0.00117	CcSEcCtD
Sulfamethoxazole—Vomiting—Ibandronate—osteoporosis	0.000302	0.00117	CcSEcCtD
Sulfamethoxazole—Headache—Raloxifene—osteoporosis	0.0003	0.00116	CcSEcCtD
Sulfamethoxazole—Rash—Ibandronate—osteoporosis	0.000299	0.00116	CcSEcCtD
Sulfamethoxazole—Dermatitis—Ibandronate—osteoporosis	0.000299	0.00116	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Zoledronate—osteoporosis	0.000299	0.00116	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000298	0.00115	CcSEcCtD
Sulfamethoxazole—Headache—Ibandronate—osteoporosis	0.000297	0.00115	CcSEcCtD
Sulfamethoxazole—Insomnia—Conjugated Estrogens—osteoporosis	0.000296	0.00114	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000296	0.00114	CcSEcCtD
Sulfamethoxazole—Vomiting—Calcitriol—osteoporosis	0.000295	0.00114	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Zoledronate—osteoporosis	0.000295	0.00114	CcSEcCtD
Sulfamethoxazole—Nausea—Estropipate—osteoporosis	0.000294	0.00114	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Pamidronate—osteoporosis	0.000294	0.00114	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Pamidronate—osteoporosis	0.000294	0.00114	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000293	0.00113	CcSEcCtD
Sulfamethoxazole—Angioedema—Estradiol—osteoporosis	0.000293	0.00113	CcSEcCtD
Sulfamethoxazole—Rash—Calcitriol—osteoporosis	0.000293	0.00113	CcSEcCtD
Sulfamethoxazole—Fatigue—Zoledronate—osteoporosis	0.000293	0.00113	CcSEcCtD
Sulfamethoxazole—Dermatitis—Calcitriol—osteoporosis	0.000293	0.00113	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000292	0.00113	CcSEcCtD
Sulfamethoxazole—Headache—Calcitriol—osteoporosis	0.000291	0.00112	CcSEcCtD
Sulfamethoxazole—Nausea—Alendronate—osteoporosis	0.00029	0.00112	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Risedronate—osteoporosis	0.000288	0.00111	CcSEcCtD
Sulfamethoxazole—Vertigo—Estradiol—osteoporosis	0.000288	0.00111	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000288	0.00111	CcSEcCtD
Sulfamethoxazole—Asthenia—Ethinyl Estradiol—osteoporosis	0.000288	0.00111	CcSEcCtD
Sulfamethoxazole—Nausea—Raloxifene—osteoporosis	0.000285	0.0011	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000284	0.0011	CcSEcCtD
Sulfamethoxazole—Pruritus—Ethinyl Estradiol—osteoporosis	0.000284	0.0011	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000282	0.00109	CcSEcCtD
Sulfamethoxazole—Fatigue—Conjugated Estrogens—osteoporosis	0.000282	0.00109	CcSEcCtD
Sulfamethoxazole—Nausea—Ibandronate—osteoporosis	0.000282	0.00109	CcSEcCtD
Sulfamethoxazole—Asthenia—Risedronate—osteoporosis	0.000281	0.00108	CcSEcCtD
Sulfamethoxazole—Cough—Estradiol—osteoporosis	0.00028	0.00108	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Zoledronate—osteoporosis	0.000278	0.00107	CcSEcCtD
Sulfamethoxazole—Pruritus—Risedronate—osteoporosis	0.000277	0.00107	CcSEcCtD
Sulfamethoxazole—Nausea—Calcitriol—osteoporosis	0.000276	0.00107	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000275	0.00106	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Pamidronate—osteoporosis	0.000274	0.00106	CcSEcCtD
Sulfamethoxazole—Myalgia—Estradiol—osteoporosis	0.000273	0.00105	CcSEcCtD
Sulfamethoxazole—Arthralgia—Estradiol—osteoporosis	0.000273	0.00105	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000271	0.00105	CcSEcCtD
Sulfamethoxazole—Urticaria—Zoledronate—osteoporosis	0.00027	0.00104	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Zoledronate—osteoporosis	0.000269	0.00104	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Zoledronate—osteoporosis	0.000269	0.00104	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Risedronate—osteoporosis	0.000268	0.00103	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000267	0.00103	CcSEcCtD
Sulfamethoxazole—Asthenia—Pamidronate—osteoporosis	0.000267	0.00103	CcSEcCtD
Sulfamethoxazole—Dizziness—Ethinyl Estradiol—osteoporosis	0.000265	0.00102	CcSEcCtD
Sulfamethoxazole—Pruritus—Pamidronate—osteoporosis	0.000263	0.00102	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Estradiol—osteoporosis	0.000262	0.00101	CcSEcCtD
Sulfamethoxazole—Urticaria—Conjugated Estrogens—osteoporosis	0.00026	0.001	CcSEcCtD
Sulfamethoxazole—Dizziness—Risedronate—osteoporosis	0.000259	0.000999	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000259	0.000999	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000259	0.000999	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Estradiol—osteoporosis	0.000257	0.000992	CcSEcCtD
Sulfamethoxazole—Vomiting—Ethinyl Estradiol—osteoporosis	0.000255	0.000985	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Pamidronate—osteoporosis	0.000254	0.000983	CcSEcCtD
Sulfamethoxazole—Skin disorder—Estradiol—osteoporosis	0.000254	0.000982	CcSEcCtD
Sulfamethoxazole—Rash—Ethinyl Estradiol—osteoporosis	0.000253	0.000977	CcSEcCtD
Sulfamethoxazole—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000253	0.000976	CcSEcCtD
Sulfamethoxazole—Headache—Ethinyl Estradiol—osteoporosis	0.000251	0.000971	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Zoledronate—osteoporosis	0.00025	0.000967	CcSEcCtD
Sulfamethoxazole—Vomiting—Risedronate—osteoporosis	0.000249	0.000961	CcSEcCtD
Sulfamethoxazole—Rash—Risedronate—osteoporosis	0.000247	0.000953	CcSEcCtD
Sulfamethoxazole—Dermatitis—Risedronate—osteoporosis	0.000246	0.000952	CcSEcCtD
Sulfamethoxazole—Dizziness—Pamidronate—osteoporosis	0.000246	0.00095	CcSEcCtD
Sulfamethoxazole—Headache—Risedronate—osteoporosis	0.000245	0.000947	CcSEcCtD
Sulfamethoxazole—Asthenia—Zoledronate—osteoporosis	0.000244	0.000941	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000241	0.000931	CcSEcCtD
Sulfamethoxazole—Pruritus—Zoledronate—osteoporosis	0.00024	0.000928	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000239	0.000921	CcSEcCtD
Sulfamethoxazole—Nausea—Ethinyl Estradiol—osteoporosis	0.000238	0.000921	CcSEcCtD
Sulfamethoxazole—Insomnia—Estradiol—osteoporosis	0.000237	0.000915	CcSEcCtD
Sulfamethoxazole—Vomiting—Pamidronate—osteoporosis	0.000236	0.000913	CcSEcCtD
Sulfamethoxazole—Asthenia—Conjugated Estrogens—osteoporosis	0.000235	0.000907	CcSEcCtD
Sulfamethoxazole—Rash—Pamidronate—osteoporosis	0.000234	0.000906	CcSEcCtD
Sulfamethoxazole—Dermatitis—Pamidronate—osteoporosis	0.000234	0.000905	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Estradiol—osteoporosis	0.000233	0.000902	CcSEcCtD
Sulfamethoxazole—Headache—Pamidronate—osteoporosis	0.000233	0.0009	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Zoledronate—osteoporosis	0.000232	0.000898	CcSEcCtD
Sulfamethoxazole—Nausea—Risedronate—osteoporosis	0.000232	0.000898	CcSEcCtD
Sulfamethoxazole—Pruritus—Conjugated Estrogens—osteoporosis	0.000231	0.000894	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Estradiol—osteoporosis	0.00023	0.00089	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Estradiol—osteoporosis	0.000228	0.000879	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Estradiol—osteoporosis	0.000226	0.000873	CcSEcCtD
Sulfamethoxazole—Fatigue—Estradiol—osteoporosis	0.000226	0.000872	CcSEcCtD
Sulfamethoxazole—Dizziness—Zoledronate—osteoporosis	0.000225	0.000868	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000224	0.000864	CcSEcCtD
Sulfamethoxazole—Nausea—Pamidronate—osteoporosis	0.000221	0.000853	CcSEcCtD
Sulfamethoxazole—Dizziness—Conjugated Estrogens—osteoporosis	0.000216	0.000836	CcSEcCtD
Sulfamethoxazole—Vomiting—Zoledronate—osteoporosis	0.000216	0.000834	CcSEcCtD
Sulfamethoxazole—Rash—Zoledronate—osteoporosis	0.000214	0.000827	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Estradiol—osteoporosis	0.000214	0.000827	CcSEcCtD
Sulfamethoxazole—Dermatitis—Zoledronate—osteoporosis	0.000214	0.000827	CcSEcCtD
Sulfamethoxazole—Headache—Zoledronate—osteoporosis	0.000213	0.000822	CcSEcCtD
Sulfamethoxazole—Vomiting—Conjugated Estrogens—osteoporosis	0.000208	0.000803	CcSEcCtD
Sulfamethoxazole—Urticaria—Estradiol—osteoporosis	0.000208	0.000803	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Estradiol—osteoporosis	0.000207	0.000799	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Estradiol—osteoporosis	0.000207	0.000799	CcSEcCtD
Sulfamethoxazole—Rash—Conjugated Estrogens—osteoporosis	0.000206	0.000797	CcSEcCtD
Sulfamethoxazole—Dermatitis—Conjugated Estrogens—osteoporosis	0.000206	0.000796	CcSEcCtD
Sulfamethoxazole—Headache—Conjugated Estrogens—osteoporosis	0.000205	0.000792	CcSEcCtD
Sulfamethoxazole—Nausea—Zoledronate—osteoporosis	0.000202	0.000779	CcSEcCtD
Sulfamethoxazole—Nausea—Conjugated Estrogens—osteoporosis	0.000194	0.00075	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Estradiol—osteoporosis	0.000193	0.000745	CcSEcCtD
Sulfamethoxazole—Asthenia—Estradiol—osteoporosis	0.000188	0.000726	CcSEcCtD
Sulfamethoxazole—Pruritus—Estradiol—osteoporosis	0.000185	0.000715	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Estradiol—osteoporosis	0.000179	0.000692	CcSEcCtD
Sulfamethoxazole—Dizziness—Estradiol—osteoporosis	0.000173	0.000669	CcSEcCtD
Sulfamethoxazole—Vomiting—Estradiol—osteoporosis	0.000166	0.000643	CcSEcCtD
Sulfamethoxazole—Rash—Estradiol—osteoporosis	0.000165	0.000638	CcSEcCtD
Sulfamethoxazole—Dermatitis—Estradiol—osteoporosis	0.000165	0.000637	CcSEcCtD
Sulfamethoxazole—Headache—Estradiol—osteoporosis	0.000164	0.000633	CcSEcCtD
Sulfamethoxazole—Nausea—Estradiol—osteoporosis	0.000156	0.000601	CcSEcCtD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00013	0.00217	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000128	0.00214	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000127	0.00213	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000127	0.00212	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—POMC—osteoporosis	0.000124	0.00207	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000117	0.00196	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000117	0.00195	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000116	0.00194	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000115	0.00193	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CAP1—osteoporosis	0.000115	0.00192	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000114	0.00191	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000113	0.00188	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000111	0.00185	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00011	0.00184	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000108	0.00181	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	0.000108	0.00181	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000107	0.0018	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ENO1—osteoporosis	0.000107	0.00179	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PSMA5—osteoporosis	0.000105	0.00176	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PSMA2—osteoporosis	0.000105	0.00176	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000105	0.00175	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—POMC—osteoporosis	0.000105	0.00175	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000104	0.00174	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000104	0.00173	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000104	0.00173	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PKM—osteoporosis	9.86e-05	0.00165	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—FDPS—osteoporosis	9.86e-05	0.00165	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—IGF1—osteoporosis	9.71e-05	0.00162	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	9.52e-05	0.00159	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.49e-05	0.00159	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	9.36e-05	0.00156	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PGLS—osteoporosis	9.35e-05	0.00156	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GPD2—osteoporosis	9.35e-05	0.00156	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.26e-05	0.00155	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	9.25e-05	0.00155	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	9.23e-05	0.00154	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	9.16e-05	0.00153	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MGLL—osteoporosis	9.15e-05	0.00153	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	9.03e-05	0.00151	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.99e-05	0.0015	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.81e-05	0.00147	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL1B—osteoporosis	8.74e-05	0.00146	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.59e-05	0.00144	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ATIC—osteoporosis	8.55e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PNP—osteoporosis	8.55e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP19A1—osteoporosis	8.55e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.55e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—POMC—osteoporosis	8.52e-05	0.00142	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.43e-05	0.00141	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8.38e-05	0.0014	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—ANXA2—osteoporosis	8.37e-05	0.0014	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PLEK—osteoporosis	8.37e-05	0.0014	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8.33e-05	0.00139	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—FDPS—osteoporosis	8.04e-05	0.00134	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PKM—osteoporosis	8.04e-05	0.00134	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	7.84e-05	0.00131	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	7.79e-05	0.0013	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GPD2—osteoporosis	7.62e-05	0.00127	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PGLS—osteoporosis	7.62e-05	0.00127	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	7.45e-05	0.00125	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	7.35e-05	0.00123	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—OXCT1—osteoporosis	7.27e-05	0.00122	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CA2—osteoporosis	7.27e-05	0.00122	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.24e-05	0.00121	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TLN1—osteoporosis	7.21e-05	0.00121	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VCL—osteoporosis	7.11e-05	0.00119	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—MGLL—osteoporosis	7.08e-05	0.00118	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.99e-05	0.00117	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ADCY5—osteoporosis	6.99e-05	0.00117	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ATIC—osteoporosis	6.97e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PNP—osteoporosis	6.97e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GPX1—osteoporosis	6.96e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	6.94e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—TGFB1—osteoporosis	6.87e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.86e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.82e-05	0.00114	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.7e-05	0.00112	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.68e-05	0.00112	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.66e-05	0.00111	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—MTHFR—osteoporosis	6.42e-05	0.00107	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TNF—osteoporosis	6.34e-05	0.00106	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	6.33e-05	0.00106	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	6.29e-05	0.00105	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—IDH2—osteoporosis	6.02e-05	0.00101	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—RAP1A—osteoporosis	5.94e-05	0.000994	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—OXCT1—osteoporosis	5.93e-05	0.00099	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CA2—osteoporosis	5.93e-05	0.00099	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—TGFB1—osteoporosis	5.82e-05	0.000973	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—MGLL—osteoporosis	5.77e-05	0.000965	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.69e-05	0.000952	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP27A1—osteoporosis	5.66e-05	0.000947	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.66e-05	0.000946	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.56e-05	0.00093	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	5.55e-05	0.000927	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ACP5—osteoporosis	5.51e-05	0.000921	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—POMC—osteoporosis	5.5e-05	0.00092	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.45e-05	0.000911	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.45e-05	0.00091	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.44e-05	0.000909	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—FGA—osteoporosis	5.39e-05	0.000901	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PKM—osteoporosis	5.19e-05	0.000868	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—FDPS—osteoporosis	5.19e-05	0.000868	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PKM—osteoporosis	5.16e-05	0.000863	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—FDPS—osteoporosis	5.16e-05	0.000863	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—POMC—osteoporosis	5.14e-05	0.000859	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—TPI1—osteoporosis	5.12e-05	0.000856	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL6—osteoporosis	5.12e-05	0.000855	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—TNF—osteoporosis	5.04e-05	0.000842	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPD2—osteoporosis	4.92e-05	0.000823	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PGLS—osteoporosis	4.92e-05	0.000823	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.92e-05	0.000822	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—IDH2—osteoporosis	4.91e-05	0.000821	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—FGB—osteoporosis	4.9e-05	0.00082	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPD2—osteoporosis	4.89e-05	0.000818	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PGLS—osteoporosis	4.89e-05	0.000818	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.85e-05	0.00081	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—P4HB—osteoporosis	4.82e-05	0.000805	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GAPDH—osteoporosis	4.73e-05	0.00079	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.63e-05	0.000775	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP27A1—osteoporosis	4.62e-05	0.000772	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—RAP1A—osteoporosis	4.6e-05	0.000769	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ATIC—osteoporosis	4.5e-05	0.000752	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PNP—osteoporosis	4.5e-05	0.000752	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ACP5—osteoporosis	4.49e-05	0.000751	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—POMC—osteoporosis	4.48e-05	0.000749	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ATIC—osteoporosis	4.48e-05	0.000748	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PNP—osteoporosis	4.48e-05	0.000748	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.43e-05	0.000741	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	4.31e-05	0.00072	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PKM—osteoporosis	4.23e-05	0.000706	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—FDPS—osteoporosis	4.23e-05	0.000706	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—TPI1—osteoporosis	4.17e-05	0.000698	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IL6—osteoporosis	4.07e-05	0.00068	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.01e-05	0.000671	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PGLS—osteoporosis	4.01e-05	0.00067	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPD2—osteoporosis	4.01e-05	0.00067	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—P4HB—osteoporosis	3.93e-05	0.000656	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GAPDH—osteoporosis	3.85e-05	0.000644	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—OXCT1—osteoporosis	3.83e-05	0.00064	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CA2—osteoporosis	3.83e-05	0.00064	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—OXCT1—osteoporosis	3.81e-05	0.000636	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CA2—osteoporosis	3.81e-05	0.000636	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—RAP1A—osteoporosis	3.75e-05	0.000627	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MGLL—osteoporosis	3.73e-05	0.000623	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ENO1—osteoporosis	3.72e-05	0.000622	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MGLL—osteoporosis	3.71e-05	0.00062	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PSMA2—osteoporosis	3.67e-05	0.000613	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PSMA5—osteoporosis	3.67e-05	0.000613	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PNP—osteoporosis	3.66e-05	0.000612	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ATIC—osteoporosis	3.66e-05	0.000612	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.52e-05	0.000588	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.5e-05	0.000585	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.27e-05	0.000547	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—IDH2—osteoporosis	3.17e-05	0.00053	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—IDH2—osteoporosis	3.15e-05	0.000527	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—OXCT1—osteoporosis	3.12e-05	0.000521	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CA2—osteoporosis	3.12e-05	0.000521	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MGLL—osteoporosis	3.04e-05	0.000507	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ENO1—osteoporosis	3.03e-05	0.000507	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PSMA2—osteoporosis	2.99e-05	0.0005	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PSMA5—osteoporosis	2.99e-05	0.0005	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.98e-05	0.000498	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP19A1—osteoporosis	2.97e-05	0.000497	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP27A1—osteoporosis	2.96e-05	0.000496	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—POMC—osteoporosis	2.95e-05	0.000494	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ACP5—osteoporosis	2.9e-05	0.000485	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ACP5—osteoporosis	2.88e-05	0.000482	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.86e-05	0.000479	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.86e-05	0.000478	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.85e-05	0.000476	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PKM—osteoporosis	2.79e-05	0.000466	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—FDPS—osteoporosis	2.79e-05	0.000466	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.72e-05	0.000454	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TPI1—osteoporosis	2.7e-05	0.000451	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TPI1—osteoporosis	2.68e-05	0.000448	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PGLS—osteoporosis	2.64e-05	0.000442	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPD2—osteoporosis	2.64e-05	0.000442	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.58e-05	0.000432	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—IDH2—osteoporosis	2.58e-05	0.000431	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—P4HB—osteoporosis	2.54e-05	0.000424	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—P4HB—osteoporosis	2.52e-05	0.000421	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GAPDH—osteoporosis	2.49e-05	0.000416	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GAPDH—osteoporosis	2.47e-05	0.000414	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ADCY5—osteoporosis	2.43e-05	0.000406	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.43e-05	0.000406	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP19A1—osteoporosis	2.43e-05	0.000405	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—RAP1A—osteoporosis	2.42e-05	0.000405	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GPX1—osteoporosis	2.42e-05	0.000405	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ATIC—osteoporosis	2.42e-05	0.000404	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PNP—osteoporosis	2.42e-05	0.000404	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—RAP1A—osteoporosis	2.41e-05	0.000403	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ACP5—osteoporosis	2.36e-05	0.000395	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.33e-05	0.00039	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—MTHFR—osteoporosis	2.24e-05	0.000374	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IGF1—osteoporosis	2.22e-05	0.000371	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TPI1—osteoporosis	2.19e-05	0.000367	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.11e-05	0.000353	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.1e-05	0.000351	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—P4HB—osteoporosis	2.06e-05	0.000345	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CA2—osteoporosis	2.05e-05	0.000343	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—OXCT1—osteoporosis	2.05e-05	0.000343	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GAPDH—osteoporosis	2.03e-05	0.000339	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MGLL—osteoporosis	2e-05	0.000335	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ADCY5—osteoporosis	1.98e-05	0.000331	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GPX1—osteoporosis	1.97e-05	0.00033	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—RAP1A—osteoporosis	1.97e-05	0.00033	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ENO1—osteoporosis	1.96e-05	0.000328	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ENO1—osteoporosis	1.95e-05	0.000326	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PSMA5—osteoporosis	1.93e-05	0.000323	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PSMA2—osteoporosis	1.93e-05	0.000323	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PSMA5—osteoporosis	1.92e-05	0.000321	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PSMA2—osteoporosis	1.92e-05	0.000321	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—MTHFR—osteoporosis	1.82e-05	0.000305	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—POMC—osteoporosis	1.79e-05	0.000299	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.72e-05	0.000288	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—IDH2—osteoporosis	1.7e-05	0.000285	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.6e-05	0.000268	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ENO1—osteoporosis	1.59e-05	0.000267	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PSMA2—osteoporosis	1.57e-05	0.000263	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PSMA5—osteoporosis	1.57e-05	0.000263	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.57e-05	0.000262	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP19A1—osteoporosis	1.56e-05	0.00026	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ACP5—osteoporosis	1.56e-05	0.00026	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—POMC—osteoporosis	1.46e-05	0.000244	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TPI1—osteoporosis	1.45e-05	0.000242	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—P4HB—osteoporosis	1.36e-05	0.000227	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GAPDH—osteoporosis	1.34e-05	0.000223	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—osteoporosis	1.33e-05	0.000223	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—RAP1A—osteoporosis	1.3e-05	0.000217	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ADCY5—osteoporosis	1.28e-05	0.000214	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPX1—osteoporosis	1.28e-05	0.000213	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.27e-05	0.000213	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ADCY5—osteoporosis	1.27e-05	0.000213	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPX1—osteoporosis	1.27e-05	0.000212	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MTHFR—osteoporosis	1.18e-05	0.000197	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MTHFR—osteoporosis	1.17e-05	0.000196	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ENO1—osteoporosis	1.05e-05	0.000176	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ADCY5—osteoporosis	1.04e-05	0.000174	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPX1—osteoporosis	1.04e-05	0.000174	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PSMA2—osteoporosis	1.04e-05	0.000173	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PSMA5—osteoporosis	1.04e-05	0.000173	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTHFR—osteoporosis	9.58e-06	0.00016	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—POMC—osteoporosis	9.41e-06	0.000157	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—POMC—osteoporosis	9.36e-06	0.000156	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.41e-06	0.000141	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—POMC—osteoporosis	7.66e-06	0.000128	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ADCY5—osteoporosis	6.87e-06	0.000115	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX1—osteoporosis	6.85e-06	0.000114	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTHFR—osteoporosis	6.32e-06	0.000106	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—POMC—osteoporosis	5.05e-06	8.45e-05	CbGpPWpGaD
